U.S. FDA approves Supernus' drug-device combination for Parkinson's disease
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat movement-related symptoms of Parkinson's disease, the drugmaker said on Tuesday.
JD Supra1d
China Unveils New Anti-Monopoly Guidelines for the Pharmaceutical Sector
China's State Council issued new Anti-Monopoly Guidelines for the Pharmaceutical Sector (the "Guidelines") effective January 24, 2025. The ...
Trump’s China tariffs are likely to drive up drug prices and spur shortages
President Donald Trump’s executive order imposing a 10% tariff on Chinese imports is likely to drive up the cost of generic ...
CounterPunch1d
Migration, Drugs, and Tariffs: Whether Biden or Trump, US’s Latin American Policy Will Still Be Contemptible
Mass deportations from the US, promised by Trump, could worsen these problems, as happened in El Salvador in the late 1990s.
STAT1d
DeepSeek signals China’s rising influence in AI — and AI drug development
There is growing enthusiasm about China’s potential to speed up drug development with AI. And companies outside the country ...
ALZFORUM5d
Leqembi Maintenance Dosing Approved in the U.S.
The U.S. Food and Drug Administration approved Eisai and Biogen’s application for IV maintenance dosing of lecanemab on January 27. Previously, the label called for biweekly IV dosing. The new ...